# Bristol-Myers Squibb Company (BMY) — Q2-2014 Earnings Results

**Report date:** 2014-07-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2014

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.28%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | +7.62% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product offerings and future growth potential. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted the continued strength in their pipeline.

> They emphasized a commitment to innovation and addressing unmet medical needs.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The management's optimistic tone regarding their pipeline suggests potential for future growth, although the lack of revenue data and guidance leaves some uncertainty. Investors may view the EPS beat as a sign of resilience in the company's performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2014_